EP0181351A4 - A method for the modulation of the immune response. - Google Patents

A method for the modulation of the immune response.

Info

Publication number
EP0181351A4
EP0181351A4 EP19850901941 EP85901941A EP0181351A4 EP 0181351 A4 EP0181351 A4 EP 0181351A4 EP 19850901941 EP19850901941 EP 19850901941 EP 85901941 A EP85901941 A EP 85901941A EP 0181351 A4 EP0181351 A4 EP 0181351A4
Authority
EP
European Patent Office
Prior art keywords
modulation
immune response
immune
response
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Withdrawn
Application number
EP19850901941
Other languages
German (de)
French (fr)
Other versions
EP0181351A1 (en
Inventor
Barry William Ninham
Robert Vincent Blanden
Robert Brian Ashman
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Australian National University
Original Assignee
Australian National University
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Australian National University filed Critical Australian National University
Publication of EP0181351A1 publication Critical patent/EP0181351A1/en
Publication of EP0181351A4 publication Critical patent/EP0181351A4/en
Withdrawn legal-status Critical Current

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/13—Amines
    • A61K31/14—Quaternary ammonium compounds, e.g. edrophonium, choline

Landscapes

  • Health & Medical Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Epidemiology (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Medicines Containing Material From Animals Or Micro-Organisms (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
EP19850901941 1984-05-09 1985-05-08 A method for the modulation of the immune response. Withdrawn EP0181351A4 (en)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
AU4895/84 1984-05-09
AUPG489584 1984-05-09

Publications (2)

Publication Number Publication Date
EP0181351A1 EP0181351A1 (en) 1986-05-21
EP0181351A4 true EP0181351A4 (en) 1989-06-21

Family

ID=3770607

Family Applications (1)

Application Number Title Priority Date Filing Date
EP19850901941 Withdrawn EP0181351A4 (en) 1984-05-09 1985-05-08 A method for the modulation of the immune response.

Country Status (3)

Country Link
EP (1) EP0181351A4 (en)
JP (1) JPS61502124A (en)
WO (1) WO1985005031A1 (en)

Families Citing this family (20)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4963557A (en) * 1987-09-28 1990-10-16 Smithkline Beecham Corporation Immunomodulatory azaspiranes
US5378696A (en) * 1990-09-19 1995-01-03 American Home Products Corporation Rapamycin esters
US5358944A (en) * 1990-09-19 1994-10-25 American Home Products Corporation Rapamycin esters for treating transplantation rejection
PT100566B (en) * 1991-06-07 1999-06-30 Smithkline Beecham Corp IMMUNOMODULATOR AZASPIRANES, PHARMACEUTICAL COMPOSITIONS CONTAINING THEM, PREPARATION AND USE
US5591748A (en) * 1991-06-07 1997-01-07 Smithkline Beecham Corporation Immunomodulatory azaspiranes
EP1004584A3 (en) * 1992-11-18 2000-07-05 Eli Lilly And Company Limited Pyranoquinoline derivatives as inhibitors of cell proliferation
US5866576A (en) * 1992-12-16 1999-02-02 Cell Therapeutics, Inc. Epoxide-containing compounds
DE4302244A1 (en) * 1993-01-27 1994-07-28 Naturwissenschaftliches Und Me Broad-spectrum antiviral chemotherapy drug and its use
TWI244923B (en) * 1997-11-11 2005-12-11 Takara Bio Inc Whitening or moisturizing cosmetics
US6420364B1 (en) * 1999-09-13 2002-07-16 Boehringer Ingelheim Pharmaceuticals, Inc. Compound useful as reversible inhibitors of cysteine proteases
DK1628987T3 (en) * 2003-05-20 2009-12-21 Pharmaxis Pty Ltd Mannose-6-phosphonate compounds for the treatment of inflammatory diseases
NZ577220A (en) * 2003-10-24 2011-01-28 Nutricia Nv Immunemodulating oligosaccharides
FR2867476B1 (en) * 2004-03-11 2006-05-26 Michel Prost GENKWANINE AND SAKURANETINE DERIVATIVES, COSMETIC AND THERAPEUTIC USE, AND PREPARATION METHOD
ES2327435T3 (en) 2004-12-02 2009-10-29 Can-Fite Biopharma Ltd. A BIOLOGICAL MARKER FOR IMFLAMATION.
WO2008011216A2 (en) 2006-05-16 2008-01-24 Pro-Pharmaceuticals, Inc. Galactose-pronged polysaccharides in a formulation for antifibrotic therapies
KR100868959B1 (en) * 2006-12-30 2008-11-17 재단법인서울대학교산학협력재단 Galactosylceramide derivatives, pharmaceutically acceptable salts thereof, preparation method and pharmaceutical composition for the immune adjuvant containing the same as an active ingredient
EP2797942B1 (en) 2011-12-28 2018-10-31 Galectin Therapeutics Inc. Composition of novel carbohydrate drug for treatment of human diseases
KR102071739B1 (en) 2012-06-06 2020-01-30 갈렉틴 테라퓨틱스, 인크. Galacto-rhamnogalacturonate compositions for the treatment of diseases associated with elevated inducible nitric oxide synthase
US9872909B2 (en) 2012-09-17 2018-01-23 Galeotin Therapeutics, Inc. Method for enhancing specific immunotherapies in cancer treatment
WO2014130648A1 (en) 2013-02-20 2014-08-28 Galectin Therapeutics, Inc. Method for treatment of pulmonary fibrosis

Family Cites Families (6)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US2653156A (en) * 1949-06-21 1953-09-22 Lehn & Fink Products Corp Quaternary ammonium compounds and process for producing the same
US3950541A (en) * 1971-09-20 1976-04-13 Waldstein David A Aqueous compositions containing quaternary ammonium salts for treatment of rectal itching and lessening of irritation and swelling of prolapsed and of irritated and swollen external hemorrhoids
US3869550A (en) * 1972-05-01 1975-03-04 Environmental Science Corp Method for the control of fertility
US4320147A (en) * 1980-05-09 1982-03-16 Lonza Inc. Disinfectant composition and the use thereof
US4330551A (en) * 1980-08-26 1982-05-18 Synergetics Co. Therapeutic method
US4450174A (en) * 1982-05-27 1984-05-22 Millmaster Onyx Group, Inc. Decyl quaternary ammonium compounds

Also Published As

Publication number Publication date
EP0181351A1 (en) 1986-05-21
WO1985005031A1 (en) 1985-11-21
JPS61502124A (en) 1986-09-25

Similar Documents

Publication Publication Date Title
DE3576280D1 (en) Ultraschall-hyperthermieapparat.
DE3578762D1 (en) Haemodiafiltrationsgeraet.
DE3586242D1 (en) Steroid-liposome.
DE3587315D1 (en) Automatisierter polypeptidsyntheseapparat.
DE3580444D1 (en) Benzoylphenylharnstoffe.
DE3576279D1 (en) Thermoplastisches polyurethanprodukt.
DE3577477D1 (en) Thermistorthermometer.
DE3583078D1 (en) Fluidmaschine.
DE3582243D1 (en) Rohrabschneider.
DE3578734D1 (en) Differentialsensor.
DE3581951D1 (en) Lsi-microcomputer.
EP0181351A4 (en) A method for the modulation of the immune response.
DE3587460D1 (en) Arylhydroxamsaeuren.
DE3587525D1 (en) Stepmotor.
DE3577993D1 (en) Phenazinfarbstoffe.
DE3584299D1 (en) Duennfilmmagnetkoepfe.
DE3580294D1 (en) Ruehrsysteme.
DE3582853D1 (en) Duennfilmmagnetkopf.
DE3579794D1 (en) Arbiterschaltung.
DE3587295D1 (en) Tomographisches testgeraet.
DE3584508D1 (en) Vinyldispersionsharz.
DE3576402D1 (en) Waegeapparat.
DE3587235D1 (en) Tricyclische thiazolderivate.
DE3582057D1 (en) Amidinverbindungen.
DE3585976D1 (en) Disaccharidderivate.

Legal Events

Date Code Title Description
PUAI Public reference made under article 153(3) epc to a published international application that has entered the european phase

Free format text: ORIGINAL CODE: 0009012

17P Request for examination filed

Effective date: 19860103

AK Designated contracting states

Kind code of ref document: A1

Designated state(s): AT BE CH DE FR GB IT LI LU NL SE

A4 Supplementary search report drawn up and despatched

Effective date: 19890621

RAP1 Party data changed (applicant data changed or rights of an application transferred)

Owner name: THE AUSTRALIAN NATIONAL UNIVERSITY

STAA Information on the status of an ep patent application or granted ep patent

Free format text: STATUS: THE APPLICATION IS DEEMED TO BE WITHDRAWN

18D Application deemed to be withdrawn

Effective date: 19890907

RIN1 Information on inventor provided before grant (corrected)

Inventor name: NINHAM, BARRY, WILLIAM

Inventor name: ASHMAN, ROBERT, BRIAN

Inventor name: BLANDEN, ROBERT, VINCENT